c-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic Target.
about
Diagnosis and Prognostic Significance of c-Met in Cervical Cancer: A Meta-AnalysisMiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer.MicroRNA-454-3p inhibits cervical cancer cell invasion and migration by targeting c-Met.MET-overexpressing myxofibrosarcoma frequently exhibit polysomy of chromosome 7 but not MET amplification, especially in high-grade cases: clinical and pathological review of 30 myxofibrosarcoma cases
P2860
c-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic Target.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
c-Met Overexpression in Cervic ...... Molecular Therapeutic Target.
@ast
c-Met Overexpression in Cervic ...... Molecular Therapeutic Target.
@en
type
label
c-Met Overexpression in Cervic ...... Molecular Therapeutic Target.
@ast
c-Met Overexpression in Cervic ...... Molecular Therapeutic Target.
@en
prefLabel
c-Met Overexpression in Cervic ...... Molecular Therapeutic Target.
@ast
c-Met Overexpression in Cervic ...... Molecular Therapeutic Target.
@en
P2093
P2860
P1476
c-Met Overexpression in Cervic ...... l Molecular Therapeutic Target
@en
P2093
Eric D Donnelly
Gayle Woloschak
Irene Helenowski
Jeffrey P Gross
Jian-Jun Wei
John Lurain
Mohamed Farouk
Natasha Berg
Prarthana Dalal
Samar El Achy
P2860
P304
P356
10.1097/COC.0000000000000203
P577
2017-12-01T00:00:00Z